Epoprostenol Sodium
Who holds supplier records for Epoprostenol Sodium? 4 organisations hold a current record for Epoprostenol Sodium: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (2), Czechia (1) and United States (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Epoprostenol Sodium: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/epoprostenol-sodium
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Epoprostenol Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CAYMAN PHARMA SROCzechia Company GMP cert on recordActive DMF 21584 · latest filing Apr 2008
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 27420 · latest filing Aug 2013
- Pharmacia & Upjohn, Inc.United StatesActive DMF 6065 · latest filing Oct 1985
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 30263 · latest filing Jan 2017
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Epoprostenol Sodium are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Taiwan · Inactive DMF 21311 · filed Feb 2008
- Sai Life Sciences LimitedIndia · Inactive DMF 19971 · filed Nov 2006
- JOHNSON MATTHEY PHARMA SERVICESInactive DMF 18019 · filed Jan 2005
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Epoprostenol Sodium is a potent vasodilator and inhibitor of platelet aggregation, used predominantly in the treatment of pulmonary arterial hypertension. It mimics the effects of endogenous prostacyclin, improving blood flow and reducing blood pressure in the lungs.
Chemical identity
- IUPAC name
- sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
- Canonical SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O.[Na+]
- InChIKey
- LMHIPJMTZHDKEW-XQYLJSSYSA-M
- Synonyms
- Flolan API, flolan, prostacyclin sodium salt, sodium prostacyclin, u-53,217a, u-53217a
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Prostacycline Vasodilator
- Physiologic effect
- Vasodilation
- Chemical structure
- Prostaglandins I
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Epoprostenol Sodium?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Epoprostenol Sodium: CAYMAN PHARMA SRO (Czechia), MSN Laboratories Private Limited (India), Pharmacia & Upjohn, Inc. (United States) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Epoprostenol Sodium Drug Master Files are active?
CAYMAN PHARMA SRO (DMF 21584), MSN Laboratories Private Limited (DMF 27420), Pharmacia & Upjohn, Inc. (DMF 6065) and Sun Pharmaceutical Industries Limited (DMF 30263). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Epoprostenol Sodium records mean?
3 organisations have only inactive Type II DMFs for Epoprostenol Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Epoprostenol Sodium supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Epoprostenol Sodium?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.